Cytomegalovirus Glycoprotein B Genotype in Hematopoietic Stem Cell Transplant Patients from China

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 5, 2010, Pages 647-652

  Wu, Xiaojin ^a   Wang, Ying ^a   Xu, Yang ^a   Wu, Depei ^a   Sun, Aining ^a   Zhu, Ziling ^a   Han, Yue ^a   Qiu, Huiying ^a   Tang, Xiaowen ^a   Fu, Zhengzheng ^a   He, Guangsheng ^a   Li, Caixia ^a   Ma, Xiao ^a   Liu, Yuejun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cytomegalovirus; Glycoprotein B; Hematopoietic stem cell transplant patients

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN B1; GLYCOPROTEIN B2; GLYCOPROTEIN B3; GLYCOPROTEIN B4; PROTEIN RSAI; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CHINA; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GENE SEQUENCE; GENOTYPE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SERODIAGNOSIS; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; CHINA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; VIRAL ENVELOPE PROTEINS; YOUNG ADULT;

EID: 77951207887     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.12.001     Document Type: Article

References (29)

1. Castagnola E., Faraci M. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation. Expert Rev Antiinfect Ther 2009, 7:607-621.
2. Boeckh M., Gooley T.A., Myerson D., et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996, 88:4063-4071.
3. Woo P.C., Lo C.Y., Lo S.K., et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997, 4:515-518.
4. Ljungman P., Camara R., Milpied E., et al. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood 2002, 99:3050-3056.
5. Fries B.C., Chou S., Boeckh M., et al. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994, 169:769-774.
6. Meyer-Konig U., Vogelberg C., Bongarts A., et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998, 55:75-81.
7. Meyer-Konig U., Haberland M., von L.D., et al. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 1998, 177:1162-1169.
8. Sinzger C., Schmidt K., Knapp J., et al. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 1999, 80:2867-2877.
9. Britt W.J., Mach M. Human cytomegalovirus glycoproteins. Intervirology 1996, 39:401-412.
10. Shepp D.H., Match M.E., Lipson S.M., et al. A fifth human cytomegalovirus glycoprotein B genotype. Res Virol 1998, 149:109-114.
11. Navarro D., Paz P., Tugizov S., et al. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993, 197:143-158.
12. Torok-Storb B., Boeckh M., Hoy C., et al. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997, 90:2097-2102.
13. Nogueira E., Ozaki K.S., Tomiyama H., et al. Granato CF. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients. Int Immunopharmacol 2009, 9:26-31.
14. Shepp D.H., Match M.E., Ashraf A.B., et al. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996, 174:184-187.
15. Bongarts A., von Laer D., Vogelberg C., et al. Glycoprotein B genotype of human cytomegalovirus: distribution in HIV-infected patients. Scand J Infect Dis 1996, 28:447-449.
16. Coaquette A., Bourgeois A., Dirand C., et al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004, 39:155-161.
17. Caliendo A.M., St.George K., Allega J., et al. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol 2002, 40:1581-1586.
18. Vogelberg C., Meyer-Konig U., Hufert F.T., et al. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996, 50:31-34.
19. Yu Z.S., Zou C.C., Zheng J.Y., et al. Cytomegalovirus gB genotype and clinical features in Chinese infants with congenital infections. Intervirology 2006, 49:281-285.
20. Chou S.W., Dennison K.M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991, 163:1229-1234.
21. Chantaraarphonkun S., Bhattarakosol P. Intra- and intergenotypic variations among human cytomegalovirus gB genotypes. Intervirology 2007, 50:78-84.
22. Humar A., Kumar D., Gilbert C., et al. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003, 188:581-584.
23. Sarcinella L., Mazzulli T., Willey B., et al. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol 2002, 24:99-105.
24. Murphy E., Yu D., Grimwood J., et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA 2003, 100:14976-14981.
25. Puchhammer-Stockl E., Gorzer I., Zoufaly A., et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006, 81:187-194.
26. Takahashi H., Furukawa T., Hashimoto S., et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000, 26:1317-1323.
27. Dickinson A.M., Cavet J., Cullup H., et al. GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum Immunol 2001, 62:1266-1276.
28. Mlynarczewska A., Wysoczanska B., Karabon L., et al. Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 2004, 34:339-344.
29. Ulbrecht M., Martinozzi S., Grzeschik M., et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol 2000, 164:5019-5022.